Building a Hit List For the Fight Against Metastatic Castration Resistant Prostate Cancer.

Building a Hit List For the Fight Against Metastatic Castration Resistant Prostate Cancer.

Cancer Biol Ther. 2016 Jan 29;:0

Authors: Strope JD, Price DK, Figg WD

Abstract
Identification of genetic alterations in Metastatic Castration Resistant Prostate Cancer (mCRPC) may provide scientists and clinicians with a list of new targets for drug research and development. Recently published in Cell, Robinson et al. present the first look at genetic data from mCRPC lesions gathered over multiple years and from many institutions.

PMID: 26822877 [PubMed - as supplied by publisher]

from Cancer via ola Kala on Inoreader http://ift.tt/1NHhvKo
via IFTTT